Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix
- 31 January 1998
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 178 (1), 113-117
- https://doi.org/10.1016/s0002-9378(98)70636-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.Journal of Clinical Pathology, 1997
- Bcl‐2 protooncogene expression in cervical carcinoma cell lines containing inactive p53Journal of Cellular Biochemistry, 1995
- BCL‐2 expression in adult and embryonic non‐haematopoietic tissuesThe Journal of Pathology, 1993
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986
- Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.Proceedings of the National Academy of Sciences of the United States of America, 1986
- Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18Cell, 1985
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984
- Distinctive Chromosomal Abnormalities in Histologic Subtypes of Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958